Strategic Advisory Board
InDevR’s Strategic Advisory Board includes an esteemed group of scientific and business leaders chosen to counsel the company on opportunities for maximizing the impact of its technologies globally. The advisors include:
Nancy Cox, Ph.D.
Dr. Nancy Cox is the retired Director of the Influenza Division at the Centers for Disease Control and Prevention, and the former Director of its WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza. During her CDC tenure, Dr. Cox helped transform the surveillance and science of influenza viruses and vaccines worldwide. She was the recipient of the Service to America Medals Federal Employee of the Year Award in 2006 and the CDC’s Lifetime Achievement Award in 2014. Time magazine named her one of 2006’s 100 Most Influential People of the Year and Newsweek magazine honored her as one of the “15 People Who Make America Great.”
Ms. Caren Mason is the CEO of STAAR Surgical and former CEO of Verinata Health, Quidel Corporation, MiraMedica and eMed Technologies. She has served on several corporate and philanthropic boards, including STAAR, HealthTell, and the Executive Committee of the University of California San Diego Moores Cancer Center Board of Visitors. Ms. Mason has significant expertise in leading strategic transformations, winning with disruptive technologies, new market building and creative commercialization.
Klaus Stöhr, Ph.D.
Dr. Klaus Stöhr was until recently Vice President and Head of Global Policy for Novartis Vaccines. Prior to Novartis he worked at WHO as coordinator of the WHO Global Influenza Program and also as Special Advisor on Influenza Pandemic Vaccine Development for the WHO Initiative for Vaccine Research. He was included in the 2005 Scientific American 50 list of research and policy leaders.
View the press release announcing the advisory board.